Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob Bor

Showing results (81-90 of 115) with videos related to

Pageof 12
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|February 6, 2025
Initiation of Dolutegravir Versus Efavirenz on Viral Suppression and Retention at 6 months: A Regression Discontinuity DesignAmy Zheng, Matthew P Fox, Ross Greener, et al.
Emerging Infectious Diseases|February 24, 2021
Decentralized Care for Rifampin-Resistant Tuberculosis, Western Cape, South AfricaSarah V Leavitt, Karen R Jacobson, Elizabeth J Ragan, et al.
Plos One|June 1, 2019
CD4 count recovery and associated factors among individuals enrolled in the South African antiretroviral therapy programme: An analysis of national laboratory based dataTendesayi Kufa, Zara Shubber, William MacLeod, et al.
Annals of Epidemiology|March 12, 2026
Initiation of Dolutegravir vs Efavirenz on 12- and 24-Month Weight, Body Mass Index, Blood Pressure, and Incident Hypertension: A Target Trial EmulationAmy Zheng, Matthew P Fox, Ross Greener, et al.
Open Forum Infectious Diseases|May 4, 2026
One- and Two-Year Outcomes of Switching to a Dolutegravir-Based ART Regimen: An Observational Emulation of Sequential Target TrialsAmy Zheng, Eleanor J Murray, Alana T Brennan, et al.
Scientific Reports|July 26, 2022
Applying machine learning and predictive modeling to retention and viral suppression in South African HIV treatment cohortsMhairi Maskew, Kieran Sharpey-Schafer, Lucien De Voux, et al.
Medrxiv : the Preprint Server for Health Sciences|May 13, 2022
Monthly excess mortality across counties in the United States during the Covid-19 pandemic, March 2020 to February 2022Eugenio Paglino, Dielle J Lundberg, Zhenwei Zhou, et al.
BMC Public Health|April 15, 2024
Integrating 'undetectable equals untransmittable' into HIV counselling in South Africa: the development of locally acceptable communication tools using intervention mappingTembeka Sineke, Jacob Bor, Rachel King, et al.
Scientific Reports|February 15, 2023
Cross-municipality migration and spread of tuberculosis in South AfricaAbdou M Fofana, Harry Moultrie, Lesley Scott, et al.
Science Advances|June 23, 2023
Monthly excess mortality across counties in the United States during the COVID-19 pandemic, March 2020 to February 2022Eugenio Paglino, Dielle J Lundberg, Zhenwei Zhou, et al.
Pageof 12

Showing results (81-90 of 115) with videos related to

Sort By:
Pageof 12
Journal of Acquired Immune Deficiency Syndromes (1999)|February 6, 2025
Initiation of Dolutegravir Versus Efavirenz on Viral Suppression and Retention at 6 months: A Regression Discontinuity DesignAmy Zheng, Matthew P Fox, Ross Greener, et al.
Emerging Infectious Diseases|February 24, 2021
Decentralized Care for Rifampin-Resistant Tuberculosis, Western Cape, South AfricaSarah V Leavitt, Karen R Jacobson, Elizabeth J Ragan, et al.
Plos One|June 1, 2019
CD4 count recovery and associated factors among individuals enrolled in the South African antiretroviral therapy programme: An analysis of national laboratory based dataTendesayi Kufa, Zara Shubber, William MacLeod, et al.
Annals of Epidemiology|March 12, 2026
Initiation of Dolutegravir vs Efavirenz on 12- and 24-Month Weight, Body Mass Index, Blood Pressure, and Incident Hypertension: A Target Trial EmulationAmy Zheng, Matthew P Fox, Ross Greener, et al.
Open Forum Infectious Diseases|May 4, 2026
One- and Two-Year Outcomes of Switching to a Dolutegravir-Based ART Regimen: An Observational Emulation of Sequential Target TrialsAmy Zheng, Eleanor J Murray, Alana T Brennan, et al.
Scientific Reports|July 26, 2022
Applying machine learning and predictive modeling to retention and viral suppression in South African HIV treatment cohortsMhairi Maskew, Kieran Sharpey-Schafer, Lucien De Voux, et al.
Medrxiv : the Preprint Server for Health Sciences|May 13, 2022
Monthly excess mortality across counties in the United States during the Covid-19 pandemic, March 2020 to February 2022Eugenio Paglino, Dielle J Lundberg, Zhenwei Zhou, et al.
BMC Public Health|April 15, 2024
Integrating 'undetectable equals untransmittable' into HIV counselling in South Africa: the development of locally acceptable communication tools using intervention mappingTembeka Sineke, Jacob Bor, Rachel King, et al.
Scientific Reports|February 15, 2023
Cross-municipality migration and spread of tuberculosis in South AfricaAbdou M Fofana, Harry Moultrie, Lesley Scott, et al.
Science Advances|June 23, 2023
Monthly excess mortality across counties in the United States during the COVID-19 pandemic, March 2020 to February 2022Eugenio Paglino, Dielle J Lundberg, Zhenwei Zhou, et al.
Pageof 12